เดกซ์โทรเมทอร์แฟน
เชิงอรรถและอ้างอิง

↑  "Dextromethorphan Monograph for Professionals". Drugs.com.
↑  Windhab, LG; Gastberger, S; Hulka, LM; Baumgartner, MR; Soyka, M; Müller, TJ;  และคณะ (2020). "Dextromethorphan Abuse Among Opioid-Dependent Patients". Clinical Neuropharmacology. 43 (5): 127–133. doi:10.1097/WNF.0000000000000403. PMID 32947422. S2CID 221798401.
↑  McCarthy, Brian (2023-11-30). "Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder". Clinical Psychopharmacology and Neuroscience. 21 (4): 609–616. doi:10.9758/cpn.23.1081. PMC 10591164. PMID 37859435.
↑  Kukanich, B; Papich, MG (October 2004). "Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs". Journal of Veterinary Pharmacology and Therapeutics. 27 (5): 337–341. doi:10.1111/j.1365-2885.2004.00608.x. PMID 15500572.
1 2 3  "Balminil DM, Benylin DM (dextromethorphan) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. สืบค้นเมื่อ 2014-04-15.
↑  "ยาแก้ไอ เดกซ์โทรเมทอร์แฟน (dextromethorphan) และการนำไปใช้ ในทางที่ผิด". โดยคณะเภสัชฯ ม.มหิดล. เก็บจากแหล่งเดิมเมื่อ 2023-12-02. สืบค้นเมื่อ 2024-11-02.
↑  Dicpinigaitis, P (2022-09-12). "The Current and Emerging Treatment Landscape for Chronic Cough". The American Journal of Managed Care. Uncovering the Economic Burden of Chronic Cough and the Promising Role of Emerging Targeted Therapies (ภาษาอังกฤษ). 28 (9): S159–S165. doi:10.37765/ajmc.2022.89244. PMID 36198074. S2CID 252736111. By sales, dextromethorphan is the most widely used OTC antitussive drug in the United States, and approximately 85% to 90% of OTC cough medicines contain dextromethorphan
↑  Majeed, A; Xiong, J; Teopiz, KM; Ng, J; Ho, R; Rosenblat, JD;  และคณะ (March 2021). "Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials". Expert Opinion on Emerging Drugs. 26 (1): 63–74. doi:10.1080/14728214.2021.1898588. PMID 33682569. S2CID 232141396.
↑  Taylor, CP; Traynelis, SF; Siffert, J; Pope, LE; Matsumoto, RR (August 2016). "Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use". Pharmacology & Therapeutics. 164: 170–182. doi:10.1016/j.pharmthera.2016.04.010. PMID 27139517.
↑  "Reference Tables: Description and Solubility - D". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2017-07-04. สืบค้นเมื่อ 2011-05-06.
1 2  Schwartz, AR; Pizon, AF; Brooks, DE (September 2008). "Dextromethorphan-induced serotonin syndrome". Clinical Toxicology. 46 (8): 771–773. doi:10.1080/15563650701668625. PMID 19238739. S2CID 37817922.
↑  
Shin, EJ; Nah, SY; Chae, JS; Bing, G; Shin, SW; Yen, TP;  และคณะ (May 2007). "Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats". Neurochemistry International. 50 (6): 791–799. doi:10.1016/j.neuint.2007.01.008. PMID 17386960. S2CID 43230896.
↑  
Shin, EJ; Nah, SY; Kim, WK; Ko, KH; Jhoo, WK; Lim, YK;  และคณะ (April 2005). "The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan". British Journal of Pharmacology. 144 (7): 908–918. doi:10.1038/sj.bjp.0705998. PMC 1576070. PMID 15723099.
↑  Fischer, J; Ganellin, CR (2006). Analogue-based Drug Discovery (ภาษาอังกฤษ). John Wiley & Sons. p. 527. ISBN 9783527607495.
↑  
Young, EC; Smith, JA (June 2011). "Pharmacologic therapy for cough". Current Opinion in Pharmacology. Elsevier BV. 11 (3): 224–230. doi:10.1016/j.coph.2011.06.003. PMID 21724464.
1 2 3  
Rossi, S, บ.ก. (2013). Australian Medicines Handbook. Adelaide: The Australian Medicines Handbook Unit Trust. ISBN 978-0-9805790-9-3. [ต้องการเลขหน้า]
↑  "Nuedexta- dextromethorphan hydrobromide and quinidine sulfate capsule, gelatin coated". DailyMed. 2019-06-23. สืบค้นเมื่อ 2020-10-23.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23  Nguyen, L; Thomas, KL; Lucke-Wold, BP; Cavendish, JZ; Crowe, MS; Matsumoto, RR (March 2016). "Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders". Pharmacology & Therapeutics. 159: 1–22. doi:10.1016/j.pharmthera.2016.01.016. PMID 26826604.
↑  "Auvelity (dextromethorphan hydrobromide/bupropion hydrochloride)" (PDF). Axsome Therapeutics. เก็บ (PDF)จากแหล่งเดิมเมื่อ 2022-08-21. สืบค้นเมื่อ 2022-08-19.
↑  Keam, SJ (November 2022). "Dextromethorphan/Bupropion: First Approval". CNS Drugs. 36 (11): 1229–1238. doi:10.1007/s40263-022-00968-4. PMID 36301443. S2CID 253158902.
1 2 3 4  "Dextromethorphan". National Highway Traffic Safety Administration (NHTSA). คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2008-08-01.
↑  
Olney, JW; Labruyere, J; Price, MT (June 1989). "Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs". Science. 244 (4910): 1360–1362. Bibcode:1989Sci...244.1360O. doi:10.1126/science.2660263. PMID 2660263.
↑  
Carliss, RD; Radovsky, A; Chengelis, CP; O'Neill, TP; Shuey, DL (July 2007). "Oral administration of dextromethorphan does not produce neuronal vacuolation in the rat brain". Neurotoxicology. 28 (4): 813–818. Bibcode:2007NeuTx..28..813C. doi:10.1016/j.neuro.2007.03.009. PMID 17573115.
↑  Dy, P; Arcega, V; Ghali, W; Wolfe, W (August 2017). "Serotonin syndrome caused by drug to drug interaction between escitalopram and dextromethorphan". BMJ Case Reports. 2017: bcr–2017–221486. doi:10.1136/bcr-2017-221486. PMC 5747823. PMID 28784915.
↑  "Inhibitors of CYP3A4". ganfyd.org. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2017-07-20. สืบค้นเมื่อ 2013-08-23.
↑  
Roth, BL; Driscol, J. "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. สืบค้นเมื่อ 2017-08-14.
↑  
Werling, LL; Keller, A; Frank, JG; Nuwayhid, SJ (October 2007). "A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder". Experimental Neurology. 207 (2): 248–257. doi:10.1016/j.expneurol.2007.06.013. PMID 17689532. S2CID 38476281.
1 2  
Taylor, CP; Traynelis, SF; Siffert, J; Pope, LE; Matsumoto, RR (August 2016). "Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use". Pharmacology & Therapeutics. 164: 170–182. doi:10.1016/j.pharmthera.2016.04.010. PMID 27139517.
↑  Raynor, K; Kong, H; Mestek, A; Bye, LS; Tian, M; Liu, J;  และคณะ (January 1995). "Characterization of the cloned human mu opioid receptor". The Journal of Pharmacology and Experimental Therapeutics. 272 (1): 423–428. PMID 7815359.
↑  Lee, JH; Shin, EJ; Jeong, SM; Lee, BH; Yoon, IS; Lee, JH;  และคณะ (June 2007). "Effects of dextrorotatory morphinans on brain Na+ channels expressed in Xenopus oocytes". European Journal of Pharmacology. 564 (1–3): 7–17. doi:10.1016/j.ejphar.2007.01.088. PMID 17346698.
↑  Gao, XF; Yao, JJ; He, YL; Hu, C; Mei, YA (2012). "Sigma-1 receptor agonists directly inhibit Nav1.2/1.4 channels". PLOS ONE. 7 (11): e49384. Bibcode:2012PLoSO...749384G. doi:10.1371/journal.pone.0049384. PMC 3489664. PMID 23139844.
1 2  Burns, JM; Boyer, EW (2013). "Antitussives and substance abuse". Substance Abuse and Rehabilitation. 4: 75–82. doi:10.2147/SAR.S36761. PMC 3931656. PMID 24648790.
↑  Chou, YC; Liao, JF; Chang, WY; Lin, MF; Chen, CF (March 1999). "Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan". Brain Research. 821 (2): 516–519. doi:10.1016/S0006-8993(99)01125-7. PMID 10064839. S2CID 22762264.
↑  Schmider, J; Greenblatt, DJ; Fogelman, SM; von Moltke, LL; Shader, RI (April 1997). "Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1". Biopharmaceutics & Drug Disposition. 18 (3): 227–240. doi:10.1002/(SICI)1099-081X(199704)18:3<227::AID-BDD18>3.0.CO;2-L. PMID 9113345. S2CID 5638973.
1 2  Morice, AH. "Cough". International Society for the Study of Cough. เก็บจากแหล่งเดิมเมื่อ 2017-05-09. Patients should take an adequate first dose of medication ie 60 mg in the adult and repeat dosing should be infrequent rather than the qds recommended.
↑  Strauch, K; Lutz, U; Bittner, N; Lutz, WK (August 2009). "Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles". Food and Chemical Toxicology. 47 (8): 1928–1935. doi:10.1016/j.fct.2009.05.004. PMID 19445995.
1 2 3 4  Yu, A; Haining, RL (November 2001). "Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?". Drug Metabolism and Disposition. 29 (11): 1514–1520. PMID 11602530. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2020-03-12. สืบค้นเมื่อ 2015-04-26.
↑  Capon, DA; Bochner, F; Kerry, N; Mikus, G; Danz, C; Somogyi, AA (September 1996). "The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans". Clinical Pharmacology and Therapeutics. 60 (3): 295–307. doi:10.1016/S0009-9236(96)90056-9. PMID 8841152. S2CID 10147669.
↑  Woodworth, JR; Dennis, SR; Moore, L; Rotenberg, KS (February 1987). "The polymorphic metabolism of dextromethorphan". Journal of Clinical Pharmacology. 27 (2): 139–143. doi:10.1002/j.1552-4604.1987.tb02174.x. PMID 3680565. S2CID 37950361.
↑  "Dextromethorphan (PIM 179)". www.inchem.org. เก็บจากแหล่งเดิมเมื่อ 2017-03-10. สืบค้นเมื่อ 2018-03-24.
↑  Meuzelaar, GJ; Neeleman, E; Maat, L; Sheldon, RA (2010-06-17). "ChemInform Abstract: A Novel Synthesis of Substituted 1-Benzyloctahydroisoquinolines by Acid-Catalyzed Cyclization of N-[2-(Cyclohex-1-enyl) ethyl]-N-styrylformamides". ChemInform. 30 (5): no. doi:10.1002/chin.199905129. ISSN 0931-7597.
1 2 3 4  Morris, H; Wallach, J (2014). "From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs". Drug Testing and Analysis. 6 (7–8): 614–632. doi:10.1002/dta.1620. PMID 24678061.
↑  "Memorandum for the Secretary of Defense" (PDF). เก็บ (PDF)จากแหล่งเดิมเมื่อ 2017-09-16. สืบค้นเมื่อ 2013-07-28.
1 2 3  "Dextromethorphan (DXM)". Cesar.umd.edu. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2018-01-06. สืบค้นเมื่อ 2013-07-28.
↑  Nordqvist C. FDA panel: cough meds should stay over the counter. Sept. 14, 2010. Medical News Today Website. http://www.medicalnewstoday.com/articles/201227.php. Accessed May 18, 2020.
↑  "Senate Bill No. 514" (PDF). An act to add Sections 11110 and 11111 to the Health and Safety Code, relating to nonprescription drugs. State of California, Legislative Counsel. เก็บ (PDF)จากแหล่งเดิมเมื่อ 2018-03-08.
↑  "BPOM Tetap Batalkan Izin Edar Obat Dekstrometorfan" [BPOM Still Cancels Dextromethorphan Drug Distribution Permit]. VIVAnews (ภาษาIndonesian). 2014-05-22. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2015-05-28.{{cite web}}:  CS1 maint: unrecognized language (ลิงก์)
↑  "SINDOnews | Berita Daerah Dan Provinsi Di Indonesia". daerah.sindonews.com (ภาษาอินโดนีเซีย). สืบค้นเมื่อ 2017-12-10. [ลิงก์เสีย]
↑  
"Pimpinan dan Apoteker Penanggung Jawab" (PDF). คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2017-08-10.
↑  
"Badan Pengawas Obat dan Makanan - Republik Indonesia". www.pom.go.id (ภาษาอังกฤษแบบอเมริกัน). คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2017-02-03. สืบค้นเมื่อ 2017-12-10.
↑  "Dextromethorphan" (PDF). Drugs and Chemicals of Concern. Drug Enforcement Administration. August 2010. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2012-10-16.
↑  Giannini, AJ (1997). Drugs of abuse (2nd ed.). Los Angeles: Practice Management Information Corp. ISBN 1570660530. [ต้องการเลขหน้า]
↑  Akerman, SC; Hammel, JL; Brunette, MF (2010-12-20). "Dextromethorphan Abuse and Dependence in Adolescents". Journal of Dual Diagnosis. 6 (3–4): 266–278. doi:10.1080/15504263.2010.537515. S2CID 70666093.
↑  Olney, N; Rosen, H (April 2010). "AVP-923, a combination of dextromethorphan hydrobromide and quinidine sulfate for the treatment of pseudobulbar affect and neuropathic pain". IDrugs. 13 (4): 254–265. PMID 20373255.
↑  Khoury, R; Marx, C; Mirgati, S; Velury, D; Chakkamparambil, B; Grossberg, GT (May 2021). "AVP-786 as a promising treatment option for Alzheimer's Disease including agitation". Expert Opinion on Pharmacotherapy. 22 (7): 783–795. doi:10.1080/14656566.2021.1882995. PMID 33615952. S2CID 231987025.
↑  Murrough, JW; Wade, E; Sayed, S; Ahle, G; Kiraly, DD; Welch, A;  และคณะ (August 2017). "Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial". Journal of Affective Disorders. 218: 277–283. doi:10.1016/j.jad.2017.04.072. PMID 28478356. S2CID 46777150.
↑  Malek, A; Amiri, S; B, Habibi Asl (2013). "The therapeutic effect of adding dextromethorphan to clonidine for reducing symptoms of opioid withdrawal: a randomized clinical trial". ISRN Psychiatry. 2013: 546030. doi:10.1155/2013/546030. PMC 3706070. PMID 23864983.